Cysteine Leukotriene Receptor Antagonist—Montelukast—Treatment Improves Experimental Abdominal Aortic Aneurysms in Mice
Cardiovascular Therapeutics · 2024
DOI: 10.1155/2024/8826287 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Therapeutics, 2024. Verfasst von Kexin Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cardiovascular Science, Translational Medicine Institute, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi 710061, China. Hauptthemen laut MEDLINE: Cyclopropanes, Sulfides, Quinolines, Acetates. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Provincial Department of Science and Technology, Tianjin Science and Technology Program.
Abstract (Originalsprache)
Background
Cysteinyl leukotrienes (LTs) and their receptors are involved in the pathogenesis of abdominal aortic aneurysms (AAAs). However, whether CysLT1 receptor antagonists such as montelukast can influence experimental nondissecting AAA remains unclear.
Methods
Nondissecting AAAs were induced in C57BL/6J mice by transient aortic luminal infusion of porcine pancreatic elastase (PPE). All animals were administrated montelukast (1 or 10 mg/kg, daily) or vehicle by gavage beginning 1 day before PPE infusion for 14 days. On day 0 (baseline) and day 14 after PPE infusion, abdominal aortic diameters were directly measured. Aortic aneurysmal segment samples were collected, and histopathological analysis was performed.
Results
Compared to vehicle treatment, montelukast significantly decreased PPE infusion–induced aortic expansion in a dose‐dependent manner (0.09‐mm reduction at a low dose and 0.19‐mm reduction at a high dose). Histopathological analysis also revealed that compared with vehicle treatment, montelukast treatment, especially in the high‐dose group, significantly improved PPE‐induced aortic elastin degradation and medial smooth muscle cell depletion. Both doses of montelukast also markedly decreased the number of local leucocytes, including macrophages, CD4 + T cells, CD8 + T cells, and B cells, infiltration and accumulation in aortic aneurysmal lesions. Montelukast treatment also downregulated matrix metalloproteinase 2 (MMP2) and MMP9 expression and inhibited mural angiogenesis in aneurysmal aortas.
Conclusion
Montelukast treatment improves experimental nondissected AAAs in mice partly by improving aortic inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Cardiovascular Science, Translational Medicine Institute, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi 710061, China.
- Department of Vascular Surgery, The Second Hospital of Tianjin Medical University, Tianjin 300211, China.
- Department of Pathology, School of Basic Medicine, Luoyang Polytechnic College, Luoyang, Henan 471000, China.
- Guangdong Provincial Key Laboratory of Large Animal Models for Biomedicine, School of Pharmacy and Food Engineering, Wuyi University, Jiangmen, Guangdong 529000, China.
- Department of Surgery, Stanford University School of Medicine, Stanford, California 94305, USA.
ORCID-Profile: Baohui Xu, Yankui Li, Sihai Zhao
Förderung
- Guangdong Provincial Department of Science and Technology
- Tianjin Science and Technology Program
Zitieren
APA
Li, K., Li, M., Wei, P., Tian, K., Liu, H., Fu, W., Hou, H., Chen, Y., Xu, B., Li, Y., & Zhao, S. (2024). Cysteine Leukotriene Receptor Antagonist—Montelukast—Treatment Improves Experimental Abdominal Aortic Aneurysms in Mice. Cardiovascular Therapeutics. https://doi.org/10.1155/2024/8826287
Vancouver
Li K, Li M, Wei P, Tian K, Liu H, Fu W, et al. Cysteine Leukotriene Receptor Antagonist—Montelukast—Treatment Improves Experimental Abdominal Aortic Aneurysms in Mice. Cardiovascular Therapeutics. 2024. doi:10.1155/2024/8826287
BibTeX
@article{Li2024,
author = {Li, Kexin and Li, Meng and Wei, Panpan and Tian, Kangli and Liu, Haole and Fu, Weilai and Hou, Haiwen and Chen, Yajie and Xu, Baohui and Li, Yankui and Zhao, Sihai},
title = {Cysteine Leukotriene Receptor Antagonist—Montelukast—Treatment Improves Experimental Abdominal Aortic Aneurysms in Mice},
journal = {Cardiovascular Therapeutics},
year = {2024},
doi = {10.1155/2024/8826287}
}
EUVIMED